V-Wave

company

About

V Wave develops an implant for the treatment of congestive heart failure.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$70M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.

The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$224M
V-Wave has raised a total of $224M in funding over 2 rounds. Their latest funding was raised on Dec 16, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 16, 2021 Series C $98M 1 Detail
Sep 22, 2020 Series C $28M 1 Detail
Apr 27, 2018 Series C $70M 1 Detail
Jan 11, 2016 Series B $28M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
V-Wave is funded by 1 investors. Triventures are the most recent investors.
Investor Name Lead Investor Funding Round
Triventures Series C